| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912274 | Lung Cancer | 2005 | 12 Pages |
Abstract
In conclusion, if the majority of NSCLC showed genetic abnormalities in the c-erbB-1 and/or c-erbB-2 gene receptor, amplification could be observed only in a few tumours and was not strictly correlated with protein expression. Finally, survival of patients expressing EGFR and/or c-erbB-2 was slightly shorter.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anne-Pascale Meert, Benoit Martin, Jean-Marc Verdebout, Sophie Noël, Vincent Ninane, Jean-Paul Sculier,